Avamys A New Nasal Spray For Allergic Rhinitis To Ease Both Nose And Eye Symptoms In An Award Winning Device
Avamys (fluticasone furoate), a new intranasal steroid (INS) manufactured by GlaxoSmithKline (GSK), launches in the UK today. In clinical trials, Avamys has shown significant improvements in both nasal and ocular symptoms in adult and adolescent patients with seasonal allergic rhinitis (SAR).1 Avamys has also demonstrated improvement in health-related quality of life domains, including eye and sleep related improvements.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment